CNVVF (Convatec Group) Cyclically Adjusted PB Ratio: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CNVVF Convatec Group PLC CNVVF
80 GF Score
Price $2.66
GF Value $3.31
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Convatec Group Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Convatec Group  (OTCPK:CNVVF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Convatec Group Cyclically Adjusted PB Ratio Related Terms


Convatec Group Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Convatec Group's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Convatec Group Cyclically Adjusted PB Ratio Chart

Convatec Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 4.51 4.34 3.48 3.09

Convatec Group Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.18 3.83 4.46 3.29 2.86

CNVVF vs ISRG, BDX, RMD: Cyclically Adjusted PB Ratio Comparison

For the Medical Instruments & Supplies subindustry, Convatec Group's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Convatec Group Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Convatec Group's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Convatec Group's Cyclically Adjusted PB Ratio falls into.


CNVVF
80GF Score
Convatec Group PLC CNVVF
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Convatec Group Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Convatec Group's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec25 is calculated as:

For example, Convatec Group's adjusted Book Value per Share data for the fiscal year that ended in Dec25 was:

Adj_Book=Book Value per Share/CPI of Dec25 (Change)*Current CPI (Dec25)
=0.741/139.9000*139.9000
=0.741

Current CPI (Dec25) = 139.9000.

Convatec Group Annual Data

Book Value per Share CPI Adj_Book
201612 0.647 102.200 0.886
201712 0.782 105.000 1.042
201812 0.824 107.100 1.076
201912 0.789 108.500 1.017
202012 0.835 109.400 1.068
202112 0.842 114.700 1.027
202212 0.792 125.300 0.884
202312 0.827 130.500 0.887
202412 0.826 135.100 0.855
202512 0.741 139.900 0.741

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Convatec Group (CNVVF) Overvalued in 2026?

Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued. The current stock price of $2.66 is trading 19.6% below its estimated GF Value™ of $3.31. GuruFocus considers Convatec Group to be Modestly Undervalued.

Key valuation signals for CNVVF:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $3.31 vs. price of $2.66 (19.6% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the CNVVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Convatec Group Business Description

Address 20 Eastbourne Terrace, 7th Floor, London, GBR, W2 6LG
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
80GF Score

Get the complete analysis for CNVVF

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.66
Price
$3.31
GF Value